The U.S. Neuromodulation market is projected to grow from USD 10.91 billion in 2026 to USD 27.69 billion by 2035, driven by rising neurological disorders, technological advancements, and demand for minimally invasive treatments.
Speak with a healthcare analyst about your research, consulting, or platform needs.